REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 112 filers reported holding REVANCE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,913,000 | -11.0% | 98,129 | -25.5% | 0.00% | 0.0% |
| Q4 2021 | $2,149,000 | -37.2% | 131,661 | +7.2% | 0.00% | 0.0% |
| Q3 2021 | $3,423,000 | -22.9% | 122,860 | -17.9% | 0.00% | 0.0% |
| Q2 2021 | $4,437,000 | -67.9% | 149,684 | -69.3% | 0.00% | -80.0% |
| Q4 2020 | $13,814,000 | -12.9% | 487,436 | -22.8% | 0.01% | -28.6% |
| Q3 2020 | $15,869,000 | +1.5% | 631,215 | -1.4% | 0.01% | 0.0% |
| Q2 2020 | $15,627,000 | +78.4% | 639,861 | +8.1% | 0.01% | +40.0% |
| Q1 2020 | $8,759,000 | -9.1% | 591,763 | -0.3% | 0.01% | +25.0% |
| Q4 2019 | $9,635,000 | +56.8% | 593,664 | +25.6% | 0.00% | +100.0% |
| Q3 2019 | $6,145,000 | +21.4% | 472,646 | +21.1% | 0.00% | 0.0% |
| Q2 2019 | $5,062,000 | -14.1% | 390,328 | +4.4% | 0.00% | 0.0% |
| Q1 2019 | $5,893,000 | +29.7% | 373,904 | +65.7% | 0.00% | 0.0% |
| Q4 2018 | $4,543,000 | +141.3% | 225,708 | +197.9% | 0.00% | +100.0% |
| Q3 2018 | $1,883,000 | – | 75,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |